A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PHA

Search Conditions:
Search Keyword : PHA
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 5 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: PHA
Appearance Frequency: 8662 time(s)
Long forms: 303

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
phytohemagglutinin
(6381 times)
Allergy and Immunology
(2321 times)
Con A (1100 times)
IL-2 (672 times)
PBMC (649 times)
1965 [Preservation by phytohemagglutinin (PHA) on the medullo-restorative and hematopoietic properties of bone marrow cells cultivated in vitro].
polyhydroxyalkanoate
(1264 times)
Microbiology
(374 times)
PHB (138 times)
3HB (63 times)
3HV (51 times)
1983 Polymeric Beta-Hydroxyalkanoates from Environmental Samples and Bacillus megaterium.
passive hemagglutination
(188 times)
Microbiology
(66 times)
ELISA (19 times)
CF (12 times)
EIA (12 times)
1966 Adenovirus antibody measured by the passive hemagglutination test.
pseudohypoaldosteronism
(66 times)
Endocrinology
(24 times)
ENaC (11 times)
MR (11 times)
CAH (4 times)
1982 [Pseudohypoaldosteronism: familial forms. Eight case-reports, with a review of the literature (author's transl)].
primary hyperaldosteronism
(49 times)
General Surgery
(10 times)
ARR (6 times)
APA (5 times)
AVS (5 times)
1982 Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism.
proper hepatic artery
(40 times)
General Surgery
(12 times)
CHA (15 times)
GDA (12 times)
LHA (7 times)
1989 [Collateral circulation after the division of the common hepatic artery--experimental study in dogs].
Phaseolus vulgaris agglutinin
(39 times)
Neurology
(5 times)
Con A (10 times)
PNA (3 times)
RCA (3 times)
1975 Recognition at cell surfaces: phytohaemagglutinin-lymphocyte interaction.
proliferation activated with phytohemagglutinin
(28 times)
Allergy and Immunology
(7 times)
PBMC (11 times)
IL-2 (10 times)
IFN-gamma (7 times)
1987 Immunomodulatory effects of orally-administered saponins and nonspecific resistance against rabies infection.
posterior hypothalamic area
(25 times)
Brain
(6 times)
AHA (5 times)
WKY (3 times)
ANP (2 times)
1976 Inhibition of thalamic and hypothalamic somatosensory evoked potentials by stimulation of substantia nigra and its modification by morphine and methotrimeprazine (levomepromazine).
10  Pelger-Huet anomaly
(22 times)
Hematology
(5 times)
LBR (3 times)
DCM (2 times)
FPLD (2 times)
1980 Functional and metabolic studies of polymorphonuclear leukocytes in the congenital Pelger-Huet anomaly.
11  Phaseolus vulgaris
(22 times)
Biochemistry
(3 times)
Con A (9 times)
LCA (4 times)
ABC (3 times)
1969 [Isolation of the PHA (Phaseolus vulgaris) receptor from swine blood cells].
12  porous hydroxyapatite
(20 times)
Dentistry
(7 times)
DHA (2 times)
FPHA (2 times)
Col (1 time)
1988 Porous hydroxylapatite granules and blocks as alveolar ridge augmentation materials: a preliminary report.
13  persistent hypoglossal artery
(13 times)
Radiology
(5 times)
ICA (3 times)
CT (2 times)
MR (2 times)
2002 Chondroblastoma of the temporal bone associated with a persistent hypoglossal artery.
14  Primary hepatic angiosarcoma
(13 times)
Medicine
(3 times)
CEUS (3 times)
AJCC (1 time)
ALB (1 time)
2003 Clinical manifestations of primary hepatic angiosarcoma.
15  PPD and phytohaemagglutinin
(12 times)
Allergy and Immunology
(4 times)
PPD (2 times)
ANAE (1 time)
CaATPase (1 time)
1979 Alpha-naphthyl acetate esterase activity in human lymphocytes: distribution in lymphocyte subpopulations and in mitogen-activated cells.
16  primitive hypoglossal artery
(12 times)
Neurosurgery
(7 times)
PTA (2 times)
AVMs (1 time)
BA (1 time)
1983 [Moyamoya disease associated with persistent primitive trigeminal artery-Report of two cases].
17  pulse height analysis
(12 times)
Biophysics
(7 times)
CRLB (2 times)
SNR (2 times)
CFOV (1 time)
1982 Multi-parameter, computer controlled operation of a FACS II cell sorter.
18  peat humic acid
(10 times)
Environmental Health
(9 times)
FA (2 times)
HA (2 times)
HOC (2 times)
2001 Americium binding to humic acid.
19  people living with HIV/AIDS
(10 times)
Acquired Immunodeficiency Syndrome
(6 times)
AOR (2 times)
ART (2 times)
QOL (2 times)
1999 Providing support to caregivers and self-care.
20  phenylhydroxylamine
(10 times)
Toxicology
(3 times)
CO (3 times)
NB (3 times)
2-Cl-A (1 time)
1975 [Formation of sulfhemoglobin using various drugs].
21  phytohemagglutinin lectin
(9 times)
Allergy and Immunology
(3 times)
PBMC (2 times)
CFSE (1 time)
Con A (1 time)
1982 Characterization of immunoregulatory T lymphocytes during ageing by monoclonal antibodies.
22  Progressive hemifacial atrophy
(9 times)
General Surgery
(5 times)
AFG (1 time)
ANA (1 time)
CT (1 time)
2005 [Free fat flap for the treatment of Parry-Romberg disease in children].
23  posthypnotic amnesia
(7 times)
Psychology
(5 times)
DF (3 times)
DRM (1 time)
HS (1 time)
1989 Directed forgetting and posthypnotic amnesia: information processing and social contexts.
24  Public Health Act
(7 times)
Public Health
(3 times)
EDs (1 time)
GEF (1 time)
HIA (1 time)
2008 [How to implement a unique triage system in the emergency departments of Latium, Italy].
25  Phaseolus vulgaris lectin
(6 times)
Biology
(2 times)
Con A (4 times)
DB (1 time)
LC (1 time)
1979 Isolation of Phaseolus vulgaris lectin (PHA) by affinity chromatography on concanavalin A--sepharose 4B gel.
26  poly(hydroxamic acid)
(6 times)
Chemistry
(2 times)
ATR-FTIR (2 times)
EDTA (1 time)
EDXRF (1 time)
1993 [A comparative study of the antioxidant properties of polyhydroxamic acids, desferal and other iron chelating agents].
27  polyclonal activators, phytohaemagglutinin
(6 times)
Allergy and Immunology
(4 times)
PBMC (2 times)
PWM (2 times)
CLL (1 time)
1982 The roles of leukaemic and residual normal cells in the proliferative response of chronic lymphocytic leukaemic lymphocytes to mitogens.
28  Pyogenic hepatic abscess
(6 times)
Genetics
(1 time)
PD (1 time)
1994 [Pyogenic liver abscess. Study of 20 patients treated with percutaneous drainage].
29  paternal history of alcoholism
(5 times)
Psychiatry
(3 times)
FHN (3 times)
AVP (1 time)
MHA (1 time)
2004 Effect of ethanol on hypothalamic-pituitary-adrenal system response to psychosocial stress in sons of alcohol-dependent fathers.
30  Personal Health Application
(5 times)
Medical Informatics
(5 times)
PHR (2 times)
ELSI (1 time)
LGPL (1 time)
2010 Combining iGoogle and personal health records to create a prototype personal health application for diabetes self-management.
31  phase, after stimulation with phytohemagglutinin
(5 times)
Biochemistry
(2 times)
Con A (1 time)
HM (1 time)
HPD (1 time)
1984 Time-resolved fluorescence spectroscopy of hematoporphyrin-derivative in human lymphocytes.
32  presence and absence of phytohemagglutinin
(5 times)
Clinical Laboratory Techniques
(1 time)
PBLs (2 times)
HIV-1 (1 time)
IFN-gamma (1 time)
1973 The response to phytohaemagglutinin (PHA) of lymphocytes from cancer patients.
33  6-phosphonohexanoic acid
(4 times)
Biochemistry
(1 time)
AFM (2 times)
CV (2 times)
EDX (2 times)
2016 Efficient functionalization of magnetite nanoparticles with phosphonate using a one-step continuous hydrothermal process.
34  people with HIV/AIDS
(4 times)
Public Health
(2 times)
--- 2008 Acupuncture use among people living with HIV/AIDS in Northern Thailand: motives, barriers, and attitudes.
35  phytohemagglutinin-stimulated
(4 times)
Medicine
(1 time)
IL-2 (1 time)
KS/AIDS (1 time)
MSA (1 time)
1979 [Inhibition of phytohemagglutinin-stimulated lymphocyte transformation by neutral SH-dependent proteinase of the spleen].
36  post-hyperventilation apnea
(4 times)
Pulmonary Medicine
(2 times)
CI (1 time)
HVS (1 time)
PB (1 time)
1982 Apnea following hyperventilation in man.
37  propionohydroxamic acid
(4 times)
Urology
(2 times)
--- 1984 [Crystalluria during prophylactic treatment of urinary lithiasis with allopurinol, hydrochlorothiazide, manganese oxide, diphosphonates and propionohydroxamic acid].
38  Prospective Hazard Analysis
(4 times)
Hospitals
(2 times)
EOP (1 time)
FMEA (1 time)
NG (1 time)
2012 Ergonomic risk assessment of nasogastric tube placement and implications for design and training.
39  purified humic acid
(4 times)
Environmental Health
(3 times)
DM (1 time)
HAS (1 time)
LAS (1 time)
2009 The root application of a purified leonardite humic acid modifies the transcriptional regulation of the main physiological root responses to Fe deficiency in Fe-sufficient cucumber plants.
40  mitogens--phytohemaglutinin
(3 times)
Pediatrics
(1 time)
Con A (2 times)
PPD (2 times)
PWM (2 times)
1991 Maternal fetal immunological relationship particularly mycobacterial immunity.
41  para hydroxy alverine
(3 times)
Chemistry Techniques, Analytical
(2 times)
ALV (3 times)
ESI (1 time)
MRM (1 time)
2009 Validated LC-MS/MS method for determination of Alverine and one of its hydroxy metabolites in human plasma along with its application to a bioequivalence study.
42  pathological health anxiety
(3 times)
Neurology
(2 times)
CI (1 time)
NSCFs task (1 time)
2016 Interoception in pathological health anxiety.
43  PBL after phytohemagglutinin
(3 times)
Allergy and Immunology
(2 times)
PBL (2 times)
Con A (1 time)
HLA-DR (1 time)
1990 Peripheral blood lymphocytes of nonleukemic lymphoma patients exhibit aberrant expression of T-cell activation markers after polyclonal stimulation in vitro.
44  pentenoate-functionalized hyaluronic acid
(3 times)
Biomedical Engineering
(3 times)
DBM (1 time)
DVC (1 time)
DVM (1 time)
2018 Superior calvarial bone regeneration using pentenoate-functionalized hyaluronic acid hydrogels with devitalized tendon particles.
45  persistent hyaloid artery
(3 times)
Ophthalmology
(2 times)
BCVA (1 time)
OCT (1 time)
PPV (1 time)
1999 Congenital ocular anomalies and ventricular septal defect in a dromedary camel (Camelus dromedarius).
46  PHA-g-AA
(3 times)
Biomimetics
(3 times)
FBs (2 times)
Col (1 time)
SCG (1 time)
2015 Influence of modified polyester on the material properties of collagen-based biocomposites and in vitro evaluation of cytocompatibility.
47  phenylalanine hydroxylase
(3 times)
Genetics, Medical
(1 time)
ALA (1 time)
ddF (1 time)
LA (1 time)
1998 [Detection of the mutant phenylalanine hydroxylase gene by dideoxy fingerprinting].
48  phosphatase
(3 times)
Therapeutics
(1 time)
gamma-GT (2 times)
GOT (2 times)
GPT (2 times)
2014 Liver damage in automotive and industrial workers of the glass.
49  preliminary hazard analysis
(3 times)
Occupational Medicine
(1 time)
ETA (1 time)
FMEA (1 time)
FTA (1 time)
1991 An overview of process hazard evaluation techniques.
50  Process hazard analysis
(3 times)
Environmental Health
(3 times)
HAZOP (1 time)
MAT (1 time)
2004 Evaluating and assessing process hazard analyses.
51  prone horizontal abduction
(3 times)
Sports Medicine
(1 time)
EC (1 time)
EMG (1 time)
ER (1 time)
2014 Immediate effects and short-term retention of multi-modal instruction compared to written only on muscle activity during the prone horizontal abduction exercise in individuals with shoulder pain.
52  protamine-heparin aggregates
(3 times)
Pathology
(3 times)
GEC (1 time)
GECs (1 time)
PA (1 time)
1981 Evidence of glomerular epithelial cell endocytosis in vitro.
53  protein and polyhydroxyalkanoates
(3 times)
Environmental Health
(2 times)
EBPR (1 time)
FISH (1 time)
GAO (1 time)
2011 Recombinant protein production by in vivo polymer inclusion display.
54  Public health agencies
(3 times)
Health Services Research
(1 time)
CMHA (1 time)
CS (1 time)
EDS (1 time)
1997 Collaboration between local public health and community mental health agencies.
55  p-hydroxyamphetamine
(2 times)
Pharmacology
(1 time)
PMA (2 times)
5-HT (1 time)
GC (1 time)
1977 The metabolism of p-methoxyamphetamine in dog and monkey. O-demethylation as a major route.
56  p-hydroxyanisole
(2 times)
Molecular Biology
(1 time)
BHA (1 time)
COX-2 (1 time)
DFT (1 time)
2009 Simulation of IR and Raman spectra of p-hydroxyanisole and p-nitroanisole based on scaled DFT force fields and their vibrational assignments.
57  pancreatic head adenocarcinoma
(2 times)
Gastroenterology
(1 time)
aHRs (1 time)
CIs (1 time)
MBSS (1 time)
2014 McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinoma.
58  para-aminohippurate
(2 times)
Ophthalmology
(1 time)
RPE (1 time)
1998 Plasma-to-lumen clearance of para-aminohippurate can replace 51Cr EDTA clearance in the evaluation of intestinal mucosal injury.
59  PCC activity in phytohemagglutinin
(2 times)
Dermatology
(1 time)
PCC (1 time)
PTKs (1 time)
pTyr (1 time)
1995 Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis.
60  peptides and the mitogen phytohemagglutinin
(2 times)
Transplantation
(1 time)
IL-2R (1 time)
PPDs (1 time)
TB (1 time)
2004 Synthetic peptides mapping to epitopes of the extracellular domain of the interleukin-2 receptor beta-chain to inhibit T-cell activation.
61  percentage of humic acids
(2 times)
Environmental Health
(2 times)
DOC (2 times)
DP (2 times)
FTIR (2 times)
2014 Fourier transform infrared spectroscopy and partial least square regression for the prediction of substrate maturity indexes.
62  personal health assistant
(2 times)
app (1 time)
2016 A feasibility pilot using a mobile personal health assistant (PHA) app to assist stroke patient and caregiver communication after hospital discharge.
63  PhaP and polyhydroxyalkanoate
(2 times)
General Surgery
(1 time)
DNA (1 time)
MMP (1 time)
PGA (1 time)
1999 Tissue engineering of autologous aorta using a new biodegradable polymer.
64  phorbol myristate acetate
(2 times)
Neoplasms
(1 time)
LPS (2 times)
AML (1 time)
Bach1 (1 time)
1992 Effects of phorbol myristate and ionomycin on in vitro growth of aged Peyer's patch T and B cells.
65  phosphatidylhydroxyacetone
(2 times)
Biochemistry
(2 times)
PA (2 times)
CL/PC (1 time)
cyt c (1 time)
2009 Free radical fragmentation of cardiolipin by cytochrome c.
66  phosphorus and polyhydroxyalkanoates
(2 times)
Environmental Health
(2 times)
--- 2002 Change in metabolism of PHA accumulation by activated sludge modifying operating conditions.
67  photoinduced hydroxylaminolysis
(2 times)
Biophysics
(1 time)
bR (2 times)
HA (1 time)
RO (1 time)
2009 Optical characteristics of polymer films based on bacteriorhodopsin for irreversible recording of optical information.
68  phytohaemagglutinin skin test
(2 times)
Molecular Biology
(1 time)
ROMs (1 time)
2006 Effects of T-cell-mediated immune response on avian oxidative stress.
69  phytohaemagglutinin-containing
(2 times)
Neoplasms
(2 times)
LA (2 times)
1995 Switching between control and phytohaemagglutinin-containing diets affects growth of Krebs II ascites cells and produces differences in the levels of putrescine, spermidine and spermine.
70  pinhole array
(2 times)
Biomedical Engineering
(1 time)
FOV (1 time)
NIF (1 time)
2016 Design of the polar neutron-imaging aperture for use at the National Ignition Facility.
71  plant antigens: phytohemagglutinin
(2 times)
Internal Medicine
(1 time)
PBMCs (1 time)
PWM (1 time)
1973 [Blastic transformation of lymphocytes induced by plant antigens: phytohemagglutinin (PHA) and pokeweed mitogen (PWM) in patients with liver cirrhosis].
72  Polyhydroxyalkanoate synthase
(2 times)
Biochemistry
(1 time)
HB-CoA (1 time)
PHB (1 time)
WT (1 time)
1999 PHA synthase from chromatium vinosum: cysteine 149 is involved in covalent catalysis.
73  polyhydroxyaromatics
(2 times)
Environmental Health
(2 times)
EfOM (1 time)
GC/MS (1 time)
MW (1 time)
2001 Extraction and characterization of organic matter from surface waters (reservoir of Keddara in Algeria).
74  polyhydroxyl acids
(2 times)
Dermatology
(2 times)
CD (1 time)
Dsg1 (1 time)
GL (1 time)
2004 The polyhydroxy acid gluconolactone protects against ultraviolet radiation in an in vitro model of cutaneous photoaging.
75  post-hatch using phytohemagglutinin
(2 times)
Molecular Biology
(1 time)
SRBC (1 time)
2007 Maternal and dietary carotenoids interactively affect cutaneous basophil responses in growing chickens (Gallus gallus domesticus).
76  primary healthcare area
(2 times)
Chemistry, Clinical
(1 time)
CPAP (1 time)
ESS (1 time)
JCAHO (1 time)
2001 Quality assurance of point-of-care testing in the Costa del Sol Healthcare Area (Marbella, Spain).
77  Primary hepatic amyloidosis
(2 times)
Gastroenterology
(2 times)
ALP (1 time)
ASCT (1 time)
HDM (1 time)
2012 Primary hepatic amyloidosis: a mini literature review and five cases report.
78  primary hypogonadotropic amenorrhea
(2 times)
Endocrinology
(2 times)
GnRHa (1 time)
HH (1 time)
MFO (1 time)
1991 Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
79  Provisional Health Advisory
(2 times)
Environmental Health
(2 times)
SPE (2 times)
HQ (1 time)
LOD (1 time)
2012 Analysis of perfluoroalkyl substances in waters from Germany and Spain.
80  pseudo-Pelger Huet anomaly
(2 times)
Hematology
(1 time)
AML (1 time)
HGA (1 time)
MDS (1 time)
2015 Pseudo-Pelger-Huet anomaly and granulocytic dysplasia associated with human granulocytic anaplasmosis.
81  pseudohypoaldosteronism type I
(2 times)
Genetics, Medical
(1 time)
CA12 (1 time)
ENaC (1 time)
PRA (1 time)
1986 Pseudohypoaldosteronism: decreased aldosterone levels with age without significant change in urinary sodium excretion.
82  Pulmonary Hypertension Association
(2 times)
Pulmonary Circulation
(1 time)
PAH (1 time)
PH (1 time)
PHCCs (1 time)
2015 Participant expectations in pulmonary hypertension-related research studies.
83  2-propylhexanoic acid
(1 time)
Drug Therapy
(1 time)
CHCA (1 time)
EPA (1 time)
VPA (1 time)
1979 Gas chromatographic method for the determination of valproic acid in human plasma.
84  ALA-PDT and induced with phytohaemagglutinin
(1 time)
Biology
(1 time)
ALA-PDT (1 time)
BFU-E (1 time)
BrdU (1 time)
1998 Selective destruction of leukaemic cells by photo-activation of 5-aminolaevulinic acid-induced protoporphyrin-IX.
85  allogeneic--phytohaemagglutinin
(1 time)
Allergy and Immunology
(1 time)
CTL (1 time)
DC (1 time)
HIV (1 time)
1991 Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.
86  aniline--phenylhydroxylamine
(1 time)
Toxicology
(1 time)
MetHb (1 time)
RBC (1 time)
2005 Aniline derivative-induced methemoglobin in rats.
87  assay-phytohaemaglutinin
(1 time)
Hematology
(1 time)
APC (1 time)
CD40L (1 time)
FVIII (1 time)
2000 Effect of factor VIII concentrate on antigen-presenting cell (APC)/T-cell interactions in vitro: relevance to inhibitor formation and tolerance induction.
88  by-products into a high value product
(1 time)
Environmental Health
(1 time)
1,3-PDO (1 time)
VFA (1 time)
2018 Combined polyhydroxyalkanoates (PHA) and 1,3-propanediol production from crude glycerol: Selective conversion of volatile fatty acids into PHA by mixed microbial consortia.
89  HA pressure
(1 time)
Transplantation
(1 time)
HA (1 time)
HMP (1 time)
PV (1 time)
2012 Flow competition between hepatic arterial and portal venous flow during hypothermic machine perfusion preservation of porcine livers.
90  hypothalamic-pituitary-adrenal axis
(1 time)
Endocrinology
(1 time)
s.c (1 time)
1994 The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors.
91  hypothalamus-pituitary-adrenocortical
(1 time)
Behavioral Sciences
(1 time)
--- 2018 Independence between coping style and stress reactivity in plateau pika.
92  P expression by adherent cells, their supernatants and mitogen
(1 time)
Allergy and Immunology
(1 time)
DAC (1 time)
DL (1 time)
PBL (1 time)
1999 Modulation of perforin expression in the decidual and peripheral blood cytotoxic lymphocytes in culture.
93  p-Hydroxyphenyl lactic acid
(1 time)
Biology
(1 time)
MLC (1 time)
1984 [Immunomodulating activity of p-hydroxyphenyllactic and ascorbic acids].
94  paediatric hospital admissions
(1 time)
Environmental Health
(1 time)
RWL (1 time)
2014 Association between annual river flood pulse and paediatric hospital admissions in the Mekong Delta area.
95  Pain Health Assessment
(1 time)
Medical Informatics
(1 time)
EHR (1 time)
PRO (1 time)
2015 Patient-reported outcomes in a large community-based pain medicine practice: evaluation for use in phenotype modeling.
96  panel-like ZnO hierarchical architecture
(1 time)
Chemistry
(1 time)
DSCs (1 time)
NPs (1 time)
2013 Asymmetric ZnO panel-like hierarchical architectures with highly interconnected pathways for free-electron transport and photovoltaic improvements.
97  para-hippocampus gyrus
(1 time)
Brain
(1 time)
DLPFC (1 time)
dmPFC (1 time)
fMRI (1 time)
2018 Altered brain activation and connectivity during anticipation of uncertain threat in trait anxiety.
98  para-hydroxy-hippuric acid
(1 time)
Nephrology
(1 time)
CPA (1 time)
fMLP (1 time)
HD (1 time)
2008 The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients.
99  paradoxical hyperadiponectinemia
(1 time)
MHO (1 time)
2012 Paradoxical Hyperadiponectinemia is Associated With the Metabolically Healthy Obese (MHO) Phenotype in African Americans.
100  parahippocampal angle
(1 time)
Neurology
(1 time)
AI (1 time)
HA (1 time)
MDR (1 time)
2015 MRI characterization of temporal lobe epilepsy using rapidly measurable spatial indices with hemisphere asymmetries and gender features.